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Mitochondrial morphologyGSK3β binding of GSKIP affects neurite outgrowth, but the physiological signiﬁcance of PKA binding to GSKIP re-
mains to be determined. We hypothesized that GSKIP and GSK3βmediate cAMP/PKA/Drp1 axis signaling and
modulate mitochondrial morphology by forming a working complex comprising PKA/GSKIP/GSK3β/Drp1. We
demonstrated that GSKIP wild-type overexpression increased phosphorylation of Drp1 S637 by 7–8-fold com-
pared to PKA kinase-inactive mutants (V41/L45) and a GSK3β binding-defective mutant (L130) under H2O2
and forskolin challenge in HEK293 cells, indicating that not only V41/L45, but also L130 may be involved in
Drp1-associated protection of GSKIP. Interestingly, silencing either GSKIP or GSK3β but not GSK3α resulted in
a dramatic decrease in Drp1 S637 phosphorylation, revealing that both GSKIP and GSK3β are required in this
novel PKA/GSKIP/GSK3β/Drp1 complex. Moreover, overexpressed kinase-dead GSK3β–K85R, which retains the
capacity to bindGSKIP, but not K85Mwhich shows total loss of GSKIP-binding, has a higher Drp1 S637 phosphor-
ylation similar to the GSKIP wt overexpression group, indicating that GSK3β recruits Drp1 by anchoring rather
than in a kinase role. With further overexpression of either V41/L45P or the L130P GSKIP mutant, the elongated
mitochondrial phenotype was lost; however, ectopically expressed Drp1 S637D, a phosphomimetic mutant, but
not S637A, a non-phosphorylated mutant, restored the elongated mitochondrial morphology, indicating that
Drp1 is a downstream effector of direct PKA signaling and possibly has an indirect GSKIP function involved in
the cAMP/PKA/Drp1 signaling axis. Collectively, our data revealed that bothGSKIP andGSK3β function as anchor-
ing proteins in the cAMP/PKA/Drp1 signaling axis modulating Drp1 phosphorylation.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
Glycogen synthase kinase 3 (GSK3), a serine/threonine kinase, par-
ticipates in several signaling pathways, including the protein kinase A, Faculty ofMedicine, College of
ung 1st Road, Kaohsiung 80708,
09.
).(PKA), protein kinase B (PKB), protein kinase C (PKC), and Wingless
(Wnt) pathways. This protein plays a multifaceted physiological role
in the regulation of cell fate, signal transduction, protein synthesis,
glycogen metabolism, mitosis, and apoptosis [1,2]. Two structural ho-
mologues, GSK3α and GSK3β, have been described inmammals. Differ-
ences in the developmental expression proﬁle of GSK3α and GSK3β
imply that the regulation and functions of these 2 proteins are not
always identical [3]. GSK3β plays an important role in neuron develop-
ment by regulating the speciﬁcation of axons and dendrites [4,5]. Our
previous work also showed that GSK3β activity is negatively regulated
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neurite outgrowth in SH-SY5Y, a neuron-like cell line. While GSKIP
increases β-catenin nuclear translocation and enhances cyclin D1
expression, it down-regulates N-cadherin expression to promote cell
cycle progression in SH-SY5Y cells [6].
Our previouswork demonstrated that GSK3β also binds to Drp1 and
is involved in regulating mitochondrial morphology [7]. Drp1 is one of
the dynamin-related proteins, a large protein with an amino-terminal
GTPase domain, middle domain, insert B, and GTPase effector domain
(GED) [8]. Drp1 participates in cellular events that affect the shape,
size, distribution, remodeling, and maintenance of mitochondria in
mammalian cells [9]. Phosphorylation is an important regulator of Drp
1 activity. Interestingly, phosphorylation of Drp 1 atmultiple serine res-
idues has opposing functional and morphological effects [7,10–18].
Drp1 S637 was ﬁrst identiﬁed as a phosphorylation site for PKA and as
a dephosphorylation site for calcineurin [12–14]. Phosphorylation at
Drp1 S637 leads to an elongated mitochondrial morphology. Previous
studies have indicated that phosphorylation at Drp1 S637 has beneﬁcial
effects in starvation conditions, wheremitochondrial are observed to be
elongated [19,20] and unite to survive [21] by protecting mitochondria
from autophagosomal degradation, permitting mitochondria to maxi-
mize energy production and supplying autophagosomal membranes
[22]. In addition, GSK3β-mediated phosphorylation of Drp1 S693 is im-
portant in controllingmitochondrialmorphology under oxidative stress
[7]. However, the physiological role of such phosphorylation events re-
mains unclear.
GSKIP is a small AKAP that complexes with PKA and GSK3β and
is known to act synergistically with cAMP/PKA signaling to inhibit
GSK3β activity [23]. GSKIP also interacts directlywithGSK3β, negatively
regulating GSK3β signaling [24]. According to our previous ﬁndings,
GSK3β binding of GSKIP is involved in the control of neurite outgrowth
[6]. However, the cellular consequences of PKA binding to GSKIP remain
to be determined.
In this study, we tested: 1) Whether GSKIP and GSK3β mediate
cAMP/PKA/Drp1 axis signaling and contribute to morphological modu-
lation of mitochondria by forming a working complex comprising PKA,
GSKIP, GSK3β, and Drp1; 2) Whether and how PKA regulates Drp1
phosphorylation via the PKA/GSKIP/GSK3β/Drp1 signaling axis while
inhibiting GSK3β activity; and 3) Whether GSK3β recruits Drp1 by an-
choring or by a kinase role. We concluded that both GSKIP and GSK3β
function as anchoring proteins involved in cAMP/PKA/Drp1 axis signal-
ing, modulating Drp1 phosphorylation at Ser637 rather than Ser693.
This is the ﬁrst report of the anchoring role of GSK3β in the PKA/
GSKIP/GSK3β/Drp1 signaling axis, potentially offering new insights
into the multifaceted role of GSK3β.
2. Methods
2.1. Cell culture, differentiation and treatment
Human neuroblastoma SH-SY5Y, HeLa, and HEK293 cell lines
(American Type Culture Collection, Manassas, VA, USA) were used for
these experiments. SH-SY5Y cells were cultured in DMEM/F12, and
HeLa and HEK293 cells were cultured in DMEM (GIBCO BRL Life Tech-
nologies, Invitrogen Corporation, CA, USA). All mediawere supplement-
ed with 10% FBS, penicillin (100 U/mL), and streptomycin (100 μg/mL).
All cells were incubated at 37 °C with humidiﬁcation and 5% CO2. Cells
were cultured in 100-mm diameter dishes and fed once every three
days until they reached 70% conﬂuence. To induce neuronal differentia-
tion, SH-SY5Y cells were seeded at 1 × 106 cells/cm2 in 100-mm culture
dishes in DMEM/F12 medium containing 10% FBS. When cells were
40–50% conﬂuent, differentiation was initiated by adding 10 μM RA
(Sigma-Aldrich, St. Louis, MO, USA). The cells were kept under these
conditions for ﬁve days, changing the medium every 2 days. For
serum starvation, SH-SY5Y cells were incubated in DMEM/F12medium
without 10% FBS for 24 h. For H2O2 treatment, SH-SY5Y, HEK293, andHeLa cell lines were treated with 100 μM H2O2 (for SH-SY5Y and
HEK293) and/or 500 μM H2O2 (for HeLa) with or without 10 μM
forskolin for 24 h. After 24 h treatment, the cells were cultured in fresh
medium and subjected to further assays (HEK293 and SH-SY5Y, cell via-
bility assays and Western blotting; HeLa cells, immunocytochemistry).2.2. Cloning and DNA sequencing
To construct GFP-tagged wt and mutant GSKIP, DNA fragments
encoding GSKIP were ampliﬁed by PCR using Taq polymerase (TaKaRa/
Clontech, Madison, WI, USA). The PCR fragments were then inserted
into the BamHI and XhoI sites of the pEGFP (Clontech) vector. Site-
directed mutagenesis was used to create the GSKIP L130P (Leucine 130
to Proline) and V41/L45P (Valine 41 and Leucine 45 to Proline) mutants
using a Quickchange Lightning kit (GE Healthcare, Sunnyvale, CA, USA)
according to the manufacturer's protocol. The nucleotide sequencing
reactionwas performedwith a BigDye Terminator v3.1 Cycling Sequenc-
ing kit (Applied Biosystems,Waltham,MA, USA) and the extended prod-
ucts were resolved on an ABI PRISM 3730 Genetic Analyzer (Applied
Biosystems, Forster City, CA, USA).2.3. Transfection and RNA interference
For transient transfections, SH-SY5Y, HeLa, and HEK293 cells were
seeded onto glass coverslips at a density of 1 × 105 cells per 12-well
plate. pEGFP, pEGFP-GSKIP, pEGFP-GSKIP (L130P), pEGFP-GSKIP (V41/
L45P), pEGFP-Drp1 (S637D), or pEGFP-Drp1 (S637A) plasmid DNA
(1 μg) was transfected into the cells using Lipofectamine 2000
(Invitrogen, Carlsbad, CA, USA) according to themanufacturer's instruc-
tions. After 24 h transfection, the SH-SY5Y cells were driven to differen-
tiate by adding 10 μM of RA and incubating for ﬁve days. For Western
blots and immunoﬂuorescence, SH-SY5Y, HeLa, and HEK293 cells
were transfected with DNA (1 μg) and Lipofectamine 2000 (3 μL).
After 24 h transfection, the cells were cultured in freshmediumand fur-
ther assayed. Three different siRNA and scrambled siRNAduplexeswere
used for RNA interference assays: GSKIP (c14orf129), GSK3α, and
GSK3β. For the siRNA-mediated knockdown of GSKIP expression,
approximately 1 × 105 or 1 × 106 cells were plated onto 12-well plates
or 100 mm dishes and left to grow overnight. The following day, cells
were transfected with the siRNA duplex (ﬁnal concentration, 50 nM)
using Lipofectamine 2000.2.4. Quantitative PCR
cDNAwas synthesized from total RNA for each of the studied groups
using an ImpronII reverse transcriptase kit (Promega, Madison, WI,
USA). All primer pairs with respect to GSKIP, LC3B and GAPDH were
designed using a web-based program provided by GeneScript.com. All
were assessed and demonstrated: 1) high ampliﬁcation efﬁciency
(N96%) across a wide range of cDNA dilutions; 2) speciﬁc, single prod-
ucts in dissociation curve analysis; and 3)melting temperatures similar
to those predicted by oligonucleotide software. Quantitative PCR was
performed using Power SYBR Green dye and the ABI Step One Plus
Real Time PCR System (Applied Biosystems, Foster City, CA, USA). The
difference between the cycle thresholds (dCT) for target gene (GSKIP
and LC3B) mRNA expression was calculated by subtracting the geomet-
ricmeanof the cycle threshold for the reference gene (GAPDH) from the
cycle threshold of GSKIP mRNA. Because this dCT represents the log2-
transformed expression ratio of the target transcript to the geometric
mean of the reference gene, the relative expression level of target
gene mRNA was determined as 2-dCT. The relative target gene expres-
sion between groups was shown as fold-increases with standard
deviations.
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For immunoﬂuorescent labeling, cell cultures were rinsed sever-
al times with PBS, ﬁxed in 4% paraformaldehyde for 5 min, and
permeabilized with 0.5% Triton X-100 in PBS for 5 min. Fixed cells
were rinsed in PBS, and nonspeciﬁc binding was blocked with 5%
normal goat serum/1% bovine serum albumin in PBS (pH 7.4) for at
least 30 min at 37 °C. All subsequent antibody incubations were
carried out in the same blocking solution. After a brief wash, the
cells were incubated for 45 min at 37 °C with the primary antibody
anti-NF-200 (monoclonal; 1:500 dilution; Sigma, St. Louis, MO,
USA) or anti-GFP (polyclonal; 1:100 dilution; Santa Cruz Biotech-
nology, Santa Cruz, CA, USA). After extensive washes with PBS, the
cultures were incubated with the appropriate secondary antibody conju-
gated to either Alexa 488 or Alexa 568 (1:500 dilution; Molecular Probes,
Eugene, OR, USA) for 45min at 37 °C. Finally, the cells were incubated for
5minwith 4′-6-diamidino-2-phenylindole (DAPI; 1mg/mL; Hoffman–La
Roche, Basel, Switzerland) prior to mounting (Molecular Probes, Eugene,
OR, USA). Confocal images were obtained using an Olympus IX71 micro-
scope (using an NA 1.3, 100× Plan objective) at 0.2 mm z-steps, con-
trolled by FLUOVIEW software (Universal Imaging, Bedford Hills, NY,
USA). All images were imported into Adobe Photoshop CS5.1 for contrast
manipulation (Mitotracker and DAPI).
2.6. Western blotting and caspase activity measurement
Cell lysates were prepared using RIPA buffer, and lysate protein con-
centrations were determined using the Bio-Rad Protein Assay system
(BioRad, Hercules, CA, USA). Nuclear extracts were prepared using the
Nuclear/Cytosol Fractionation kit (Biovision Research, Milpitas, CA,
USA) according to the manufacturer's instructions. Proteins were sepa-
rated by 12% SDS-PAGE and transferred onto PVDF membranes. The
membrane was then incubated with primary antibodies: anti-GSK-3
(recognizing both GSK-3α and GSK-3β; Santa Cruz Biotechnologies),
anti-GSK3β (BD Biosciences, Franklin Lakes, NJ, USA), anti-phospho
(S9)-GSK3β (Cell Signaling Technology, Danvers, MA, USA), anti-
phospho (S637)-Drp1, anti-phospho-PKA substrates, anti-LC3B, anti-
Atg5, anti-PARP (cleavage form), anti-caspase-9/-3 (Cell Signaling Tech-
nology, Danvers, MA, USA), anti-p62 (AbCam, Cambridge, England),
anti-GFP, anti-β-catenin, anti-β-actin (Santa Cruz Biotechnology, Santa
Cruz, CA, USA), and anti-Drp1 (BD Biosciences, San Jose, CA, USA). The
secondary antibodies used were goat anti-mouse or anti-rabbit IgG
conjugated to HRP (Zymed/Invitrogen, Carlsbad, CA, USA). ECL reagents
(GE Healthcare, Little Chalfont, UK) were used to detect chemilumines-
cent signaling. Apoptosis was measured using a luminogenic caspase-
Glo 3/7 reagent according to the manufacturer's instructions (Promega,
Madison, WI, USA).
2.7. Immunoprecipitation
HEK293 cells (1 × 106) were transfected with pEGFP-GSKIP wild-
type, pEGFP-GSKIP L130P, or pEGFP-GSKIP V41/L45P DNA for 24 h.
The cells were harvested and washed with phosphate-buffered saline.
The lysates were prepared by the addition of immunoprecipitation
assay buffer (1 mL; 50 mM Tris–HCl, pH 7.8, 150 mM NaCl, 5 mM
EDTA, 0.5% Triton X-100, 0.5% Nonidet P-40, 0.1% deoxycholate, and
10 mg/mL each of leupeptin, aprotinin, and 4-[2-aminoethyl] benzene
sulfonyl ﬂuoride) to the cells. Lysates were then microcentrifuged at
10,000 ×g for 20 min and the supernatants treated with anti-GSK3β
antibody (BD Biosciences, Franklin Lakes, NJ, USA) at 48 °C for 1 h.
Protein-A/G Agarose beads (30 mL) (Calbiochem, Davis, CA, USA) were
added to the lysates, and the mixtures were incubated with shaking for
1 h at 48 °C. The beads were ﬁnally collected by centrifugation and
washed three times with immunoprecipitation assay buffer. Proteins
bound to the beads were eluted with electrophoresis sample buffer
(20 mL) and separated by SDS-PAGE. Immunoblots were visualizedusing anti-GFP antibody (Santa Cruz Biotechnology, Santa Cruz, CA,
USA), anti-Drp1 antibody (BD Biosciences, San Jose, CA, USA), or anti-
PKA RII antibody (Merck Millipore, Darmstadt, Germany).
2.8. In vitro kinase assay
The kinase reaction was carried out as described previously [6].
Brieﬂy, the full-length GSKIP and GSKIP Drp1690–736 fragments were
puriﬁed and incubated with GSK3β (25 units; New England Biolabs,
Ipswich, MA, USA) in kinase buffer (1mMNa3VO4, 1 mMdithiothreitol,
2 mM EGTA, 25 mM Tris [pH 7.2], 10 mMMgCl2, 0.1 mM ATP, 0.5 mM
PMSF, 10% glycerol, and 10 Ci of [γ-32P]ATP [GE Healthcare],
3000 Ci/mM). The assays were carried out for 15 min at 30 °C. The reac-
tionwas stoppedby adding2×sample buffer. Sampleswere denatured at
95 °C for 5 min and separated by 8% SDS-PAGE. Signals were detected by
autoradiography.
2.9. MTT assay
SH-SY5Y and HEK293 with GFP vector alone, GSKIP wt, and other
mutant stable clones were seeded onto 96-well plates at 2 × 104 cells/
well in DMEM/F12 or DMEM medium and incubated for 24 h. MTT
[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide]
was added (ﬁnal concentration, 0.5 mg/mL per well) and incubated
for 2 h (37 °C, 5% CO2). The reaction was stopped by adding DMSO,
and the formazan dye was solubilized. Optical densities were read at
595 nm using a microplate reader.
2.10. Statistical analysis
Data are presented as mean ± standard deviation. Statistical signif-
icance between the groups was examined using either Student's t-test
or Wilcoxon's Rank-Sum test. p-Values less than 0.05 were considered
statistically signiﬁcant.
3. Results and discussion
3.1. PKA, GSKIP, GSK3β, and Drp1 may form a local working complex
Wepreviously identiﬁed residue L130 of GSKIP as critical for binding
to GSK3β; cells expressing the GSKIP–L130P mutant lose inhibition of
SH-SY5Y neurite outgrowth [6,8]. In this study, we further conﬁrmed
that GFP-tagged GSKIP but not the GFP-tagged GSKIP–L130P mutant is
immunoprecipitated by anti-GSK3β antibody (Fig. 1A). This data indi-
cates that L130 is essential for GSK3β binding. Furthermore, our data
showed that PKA RII (regulatory subunit type II) subunits are also
immunoprecipitated by GFP-tagged GSKIP (Fig. 1B and C). However,
the GFP-tagged GSKIP V41/L45P mutant failed to interact with PKA RII
subunits (Fig. 1C), which is consistent with earlier reports [7]. These
data suggest that GSKIP may function as an AKAP to recruit the GSK3β
and PKA RII subunits into close proximity. These ﬁndings also suggest
that GSKIP forms a working complex with PKA RII, GSK3β, and Drp1.
Further, we examined whether GSKIP facilitates PKA-mediated phos-
phorylation of GSK3β S9. We detected a basal level of phosphorylated
GSK3β S9 in all untreated cells. However, the level was higher in cells
expressing GFP-GSKIP wt and the V41/L45P mutant than in those
expressing the L130P mutant (Fig. 1D, left panel). This observation indi-
cates that the GSK3β binding domain of GSKIP effectively increases the
phosphorylation of GSK3β S9. Forskolin is a direct activator of adenylyl
cyclases and induces a rise in cAMP to activate PKA. When treated with
forskolin, the phosphorylation level of GSK3β S9 was increased in all
groups, but the original inter-group variations in GSK3β S9 phosphoryla-
tion were abolished (Fig. 1D, right panel). Without forskolin induction,
the phosphorylation level of the L130P mutant was relatively low com-
pared to that of the other 3 groups, possibly because the L130P mutant
is unable to bind GSK3β. We believe that the low phosphorylation level
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enous GSKIP upon GSK3β activation (Fig. 1D, left panel). Together, these
results suggest that GSKIP forms a local working complex with PKA RII,
GSK3β, and Dp1 in the presence of forskolin (Fig. 1E).
We postulate a hypothetical model in which GSKIP-induced inhibi-
tion of GSK3β-mediated Drp1 function takes place in 2 steps. First,
GSKIP acts as a negative regulator of GSK3β through L130-mediated
protein–protein interaction. Second, V41/L45 serves as a critical residue
within the PKA binding domain of GSKIP. As a result, the binding of
GSKIP to PKA may synergistically affect GSK3β activity via activation of
GSK3β S9 phosphorylation. In contrast to our previous ﬁnding that
GSKIP impairs GSK3β-mediated phosphorylation of Drp1690–736 in a
dose-dependent manner (Supplemental Fig. 1) [7], the ﬁndings
shown in Fig. 1 suggest that PKA signaling is essential for regulating
Drp1 function locally. We thus speculate that GSK3β plays a multiface-
ted role in controlling Drp1 phosphorylation at multiple sites. In addi-
tion to phosphorylating Drp1 at S693 (pS693) through its kinase
activity, GSK3βmight anchor Drp1 (Fig. 1E), thereby providing a sub-
strate for PKA, which phosphorylates Drp1 at S637 (pS637) as well.Fig. 1.GSKIP directly interactswith PKA andGSK3β as anAKAP. (A)GSKIP interactswithGSK3β
and total lysates were subjected to immunoprecipitation (IP) using anti-GSK3β antibody. The p
interacts with the PKARII region. GFP-GSKIPwt transfected cells were collected, and total lysate
immunoblottingwith the anti-PKA RII antibody. (C) GFP-GSKIPwt, GFP-GSKIP L130P or GFP-GS
anti-GSK3β antibody. The resulting precipitates were then analyzed by immunoblotting with th
were transiently expressed in SH-SY5Y cells. The cells were untreated (left) or incubatedwith 1
to GFP-GSKIP, phosphorylated (p-GSK3β), total GSK3β, and PKA substrate using speciﬁc antibo
Right panel: the bar chart represents the fold-increase in phosphorylation of GSK3β Ser9 across
forskolin treatment. The ratio of p-GSK3β to GSK3βwas calculated based on triplicate experime
PKA, GSKIP, GSK3β and Drp1. “?” will be solved in this article.3.2. L130 but not V41/L45 is crucial for RA-induced neurite outgrowth, and
both V41/L45 and L130 are associated with the protective action of GSKIP
against H2O2-induced apoptosis
We previously demonstrated that overexpression of GSKIP but not
the GSKIP L130P mutant prevents neurite outgrowth of SH-SY5Y
when treated with RA [6]. Here, we further investigated whether V41/
L45, as a PKA binding site, plays a role similar to that of L130 in RA-
induced neurite outgrowth. Our data robustly demonstrate that L130
is crucial for RA-induced neurite outgrowth, and the V41/L45 residues
of GSKIP tethering it to PKA are not involved in preventing the neurite
outgrowth (Fig. 2). We further investigated stimuli that might alter
GSKIP mRNA expression. A variety of stimuli, including Wnt signaling,
glucose depletion, Aβ, H2O2, staurosporine (STS), forskolin, and insulin
were implicated, but no treatment signiﬁcantly induced GSKIP mRNA
expression (Supplemental Figs. 2A & 2B). We also investigated whether
GSKIP plays a role in autophagy and found no signiﬁcant difference in
autophagy-relatedprotein expression between the study groups (Supple-
mental Fig. 3).via its C-terminal region. GFP-GSKIPwt or GFP-GSKIPL130P transfected cellswere collected
recipitates were then analyzed by immunoblotting with the anti-GFP antibody. (B) GSKIP
s were subjected to IP using the anti-GFP antibody. The precipitateswere then analyzed by
KIP V41/L45P transfected cells were collected, and total lysates were subjected to IP using
e anti-GFP, PKA RII, and Drp1 antibodies. (D) left panel: GFP or GFP-GSKIPwt andmutants
0 μM forskolin for 1 h (right). Cells were lysed, and the protein level analyzedwith respect
dies. The dashed line indicates the region where separate blots were joined in this image.
different groups. The reference value of this bar graph is the L130Pmutant group without
nts. ⁎p b 0.05; ⁎⁎p b 0.01. (E) Schematic showing a possibleworking complex comprised of
Fig. 2. GSKIP inhibits GSK3β activity through its C-terminal domain by protein–protein interaction, not via its AKAP function. (A) The immunoreactivity of NF-200 was enhanced by RA
treatment in the GFP-GSKIP L130P stable SH-SY5Ycell line but was unaltered in the GFP-GSKIP wt and GFP-GSKIP 41/45P groups. (B) Magniﬁed patterns with respect to the GFP-GSKIP
wt, GFP-GSKIP L130P and GFP-GSKIP 41/45P groups after RA treatment in SH-SY5Y cells. White arrows indicate transfected cells. Cells overexpressing GSKIP wt lack neurites upon NF-
200 staining. (C) Quantiﬁcation of anti-NF-200-positive cells corresponding to GFP-GSKIP wt-, GFP-GSKIP L130P- and GFP-GSKIP-expressing cells. The bar chart represents results in
triplicate, and at least 200 cells are estimated for each experiment. Error bar represents SD. Y axis represents the percentage of observed cells. ⁎p b 0.05.
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we alternatively explored their role in apoptosis, since PKA-mediated
phosphorylation of Drp1 at S637 confers resistance to H2O2-induced
apoptosis [17]. A previous study suggests that S637 phosphorylation
results in elongated mitochondrial morphology [12]. We used STS and
H2O2 to induce apoptosis and mitochondrial fragmentation, respective-
ly. The basal levels of STS and H2O2 cytotoxicity were determined,
revealing that only H2O2 had a minor inﬂuence on PKA signaling (data
not shown). Cell proliferation assays usingMTT showed that after treat-
ment with either H2O2 alone or H2O2 plus forskolin, cells expressing
GSKIP wt showed relatively minor decreases in proliferation compared
to cells in other groups, indicating a possible protective effect of GSKIP
wt against oxidative stress (Fig. 3A). We determined the expression of
cleaved PARP and caspase-3 as apoptotic markers in cells treated with
H2O2 (Fig. 3B) or forskolin and H2O2 (Fig. 3C). Consistently, the expres-
sion of both cleaved PARP and caspase-3 was signiﬁcantly higher in the
V41/L45P-expressing cells than the GSKIP wt-expressing cells under 2
different conditions (H2O2 alone and H2O2 plus forskolin; Fig. 3B and
C, respectively). Similarly, the activity of caspase 3 and 7was signiﬁcant-
ly lower in GSKIP wt cells compared to those expressing either of the 2
mutants under both H2O2 and H2O2 plus forskolin treatment (Fig. 3D).
These results suggest that V41/L45 contributes to a protective effect
against H2O2-induced apoptosis. Nevertheless, expression of cleaved
caspase-3 was also higher in the L130P-expressing cells than GSKIP
wt-expressing cells. Hence, L130 may also be involved in controlling
apoptosis, even if its role is relatively minor compared to that of V41/L45.3.3. V41/L45 and L130 affect Drp1-associated GSKIP protective action
through a union of the two modes of GSKIP function involved in the
cAMP/PKA/Drp1 axis
As our results show, both V41/L45 and L130 may be involved in
GSKIP's apoptosis-controlling role. However, the downstream effector of
these 2modes of GSKIP action remains unclear. Previously, we character-
ized L130 as critical for the interaction betweenGSKP andGSK3β. In addi-
tion, Drp1 phosphorylation by GSK3β (on S693) and PKA (on S637) both
contribute to physiological neuroprotection against oxidative stress.
Therefore, we tested whether Drp1 functions as a downstream effector,
mediating the convergence of PKA and GSK3β signaling attributed to
GSKIP and leading to a protective effect against H2O2-induced mitochon-
drial fragmentation. As shown in Fig. 4, a basal level of pS637 Drp1 was
detectable in all groups. However, the level was higher in cells expressing
GFP-GSKIP wt than in other groups. Treatment with H2O2 reduced the
level of pS637 Drp1 and led to extreme mitochondrial fragmentation
but increased the expression levels of GSK3β S9 and PKA substrates.
Nonetheless, the level of pS637 Drp1 was increased by forskolin treat-
ment, consistentwith the results of a previous study [12]. These results in-
dicate that PKA signaling was induced by forskolin, which has been
presumed to affect the level of pS637Drp1.However, ourﬁndings suggest
two possible explanations for these results: 1) Another PKA-associated,
GSKIP-involved signaling pathway may be involved; and 2) GSKIP is
involved in regulating Drp1 S637 phosphorylation in this scenario
through the cAMP/PKA/Drp1 signaling axis.
Fig. 3.GSKIP is associatedwith acquired resistance to apoptosis by coordinating the activation of both the PKA andGSK3β binding domains. (A)Cell proliferation assay usingMTT showed a
signiﬁcant reduction proliferation of cells expressing V41/L45P compared to those expressing GSKIP wt. The Y axis indicates the percentage of viable cells. Reference value:
(B) Overexpression of GSKIP V41/L45P, but not L130P, signiﬁcantly increased apoptotic marker expression (cleaved PARP and caspase-3) under H2O2 insult. Reference values: (based
on lowest expression) expression level of cleaved PARP, L130P group + FSK alone; expression level of caspase-3, untreated V41/L45P mutant. (C) Overexpressed GSKIP V41/L45P or
L130P was associated with loss of acquired resistance against H2O2-induced apoptosis under activated cAMP signaling with forskolin treatment. Reference value: expression level of
caspase-3, GSKIP wt group + FSK alone ⁎p b 0.05, ⁎⁎p b 0.01. (D) The fold-increase in caspase 3/7 activity with respect to each tested group. Reference value: luminescent signal of
GFP in control group.
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Further, our data showed a signiﬁcant difference in pS637 Drp1
between cells expressing GSKIP wt and those expressing the 2 mutant
GSKIP variants under both conditions (forskolin alone and forskolin
plus H2O2). The level of pS637 Drp1 in cells expressing GSKIP wt was
7–8-fold higher than in mutant-expressing cells under both conditions
(Fig. 4, lower panel). In fact, without forskolin induction, GFP-GSKIP
wt cells still showed relatively higher levels of pS637 Drp1. These obser-
vations suggest that V41/L45 and L130 are involved in the Drp1-
associated GSKIP protective mechanism, which can be linked to cAMP/
PKA/Drp1 axis signaling.
3.4. Knockdown experiments reveal that GSKIP and GSK3β are involved in
Camp/PKA/Drp1 axis signaling
To test whether GSKIP regulates the phosphorylation of Drp1 and/or
GSK3β, we knocked down either GSKIP or GSK3 by siRNAwhile activat-
ing cAMP signaling. Additionally, we overexpressed wild-type GSKIP as
a positive control for comparisonwith the 2GSKIPmutants. As shown in
Fig. 5A, our data conﬁrmed the successfulness of GSKIP silencing at the
mRNA level, causing a 51% reduction in GSKIP mRNA expression.
Neurite outgrowth was unaffected by GSKIP knockdown (Fig. 5B),
which did not inhibit neurite outgrowth and was consistent with the
result of cells expressing the L130P mutant compared to GSKIP wt and
V41/L45P mutant (Fig. 2). Moreover, in the presence of forskolin, the
silencing of GSKIP expression led to a decrease in Drp1 S637, while
GSKIP overexpression increased the levels of pS637 Drp1 and pS9
GSK3β (Fig. 5C). These observations suggest that GSK3β acts as a scaf-
fold protein that recruits Drp1 to PKA, which directly phosphorylates
S637. The silencing of GSK3β but not GSK3α resulted in a dramatic
decrease in pS637 Drp1 (Fig. 5D & E). Further, overexpression ofkinase-dead GSK3β K85R (which retains the capacity to bind GSKIP)
but not K85M (which does not have the capacity to bind GSKIP) had
no effect on pS637 Drp1 levels (Fig. 5F). These data indicate that
GSKIP and GSK3β coordinate to strengthen cAMP/PKA/Drp1 axis signal-
ing. In addition, we observed that Drp1 phosphorylation at S637 is not
mediated through GSK3β activity but through PKA signaling. Notably,
in this case GSK3β appears to acts as an anchoring protein rather than
as a kinase.
3.5. Overexpression of GSKIP Wt but not V41/L45P and L130P mutants
decreased mitochondrial fragmentation and increased the number of
mitochondria with elongated morphology under co-administration of
H2O2 and forskolin
H2O2-induced apoptosis is usually accompanied by mitochondrial
fragmentation during cell death. Previous reports suggest that overex-
pression of Drp1 S637D, a phosphomimetic mutant, leads to elongated
mitochondrial morphology, which may be associated with acquired
resistance to H2O2-induced apoptosis [7,17]. We therefore examined the
mitochondrial morphology consequent to Drp1 S637 phosphorylation
in cells overexpressing each GSKIP variant under different conditions. As
shown in Fig. 6A–D, the mitochondrial morphology of the control group
was intermediate (~65%), with a small fraction of fragmented (~20%) or
elongated (~15%) mitochondria. With H2O2 treatment, the number of
fragmented mitochondria was greater in cells expressing the GSKIP mu-
tants (~57%) than in those expressing GSKIP wt (~42%) (Fig. 6B and D).
The number of intermediate mitochondria was slightly higher in the
GSKIP wt cells (~50%) than in the other cells (~41%). In contrast, when
cells were co-treated with forskolin and H2O2, those expressing GSKIP
wt showed a signiﬁcantly lower number of fragmented mitochondria
(~35% vs. 44%–45%) and a slightly increased number of intermediate
Fig. 4. GSKIP is associated with acquired resistance to H2O2-induced apoptosis and inﬂuences mitochondrial morphology by coordinating activation of PKA-mediated Drp1 phosphoryla-
tion at Ser637 (upper panel). The dashed line indicates the separate blot with respect to different experiment thatwas joined in this image. The bar chart represents phosphorylation levels
of Drp1 Ser637 for each group. Phosphorylation levels of Drp1 Ser637 in the GSKIP wt groupwere 7–8-fold greater than the two GSKIP mutants under both H2O2 and H2O2 plus forskolin
treatments (lower panel). Reference value: GFP group treated with H2O2. ⁎⁎p b 0.01.
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compared to cells expressing the GSKIP mutants (Fig. 6C and D).
However, it is noteworthy that when treated with forskolin alone,
all cells showed a majority of elongated mitochondria regardless of
H2O2 insult or GSKIP variant expressed (Supplemental Fig. 4). This
phenomenon is most likely the result of unopposed mitochondrial
fusion due to PKA-mediated phosphorylation of Drp1 S637 [17].
These results suggest that the mitochondrial dynamics were regulat-
ed more dominantly by PKA signaling; however, this process is also
modulated, at least in part, by GSKIP through its interaction with
PKA RII and GSK3β.
To validate and conﬁrmwhether Drp1was a downstream effector
of GSKIP's protective action against H2O2-induced apoptosis, we
ectopically expressed two Drp1 S637 mutants, S637A and S637D, in
HeLa cells. As shown in Fig. 7, overexpression of S637D, but not
S637A, restored the elongated mitochondrial morphology in cells
expressing each of the two GSKIP mutants. Together with the afore-
mentioned ﬁndings, our results reveal that phosphorylation of Drp1
S637 is indeed regulated by GSKIP via coordination of its PKA and
GSK3β binding domains. It should be noted that both GSKIP and
GSK3 function as scaffolding proteins in our hypothetical complex
(Fig. 8 and Supplemental Fig. 5). Speciﬁcally, within this complex,
GSK3 activity appears to be doubly inhibited by PKA-mediated phos-
phorylation at S9 of GSK3 and by direct protein–protein interaction
with GSKIP.
In this study, we provide the ﬁrst evidence to show that PKA/GSKIP/
GSK3β/Drp1may forma complex in vitro (Fig. 1).We further investigatedthe possible role of GSKIP V41/L45. Unlike L130, this site is unlikely to be
involved in neurite outgrowth (Fig. 2). V41/L45 was identiﬁed as
responsible forGSKIP/PKARII binding, as shownby immunoprecipitation,
where V41/L45 mutations disrupted binding to PKA (Fig. 1C). Although
V41/L45 is not involved in neurite outgrowth, it participates in PKA-
mediated Drp1 phosphorylation. We propose that L130 has a function
similar to that of V41/L45, but through a distinct mechanism (L130 func-
tion, GSK3β anchoring; V41/45 function, PKA RII binding) that partici-
pates in the control of apoptosis (Fig. 3). Further, both V41/L45 and
L130 are important for the Drp1-associated protective function of
GSKIP. We clearly demonstrated that overexpression of GSKIP wt caused
a 7–8 fold increase in pS637 Drp1 over that of the two GSKIP mutants
(Fig. 4, right panel). Conversely, knockdownof GSKIP andGSK3β revealed
that they are required for cAMP/PKA/Drp1 axis signaling under oxidative
stress (Fig. 5).
The possible biological roles of GSKIP are summarized in Table 1.
Notably, GSKIP exerts protective control on mitochondrial morphol-
ogy by coordinating the activation of PKA-mediated Drp1 phosphor-
ylation at S637 and the GSK3β-mediated Drp1 recruitment. This
recruitment is achieved by anchoring rather than the kinase activity
of GSK3, even though the GSK3β activity is supposed to be down-
regulated by GSKIP–GSK3β binding. We therefore concluded that
GSKIP and GSK3β participate in the cAMP/PKA/Drp1 axis by forming
a working complex as PKA/GSKIP/GSK3β/Drp1 to modulate mito-
chondrial morphology, which sustains cell survival and controls
neurite outgrowth. The roles of GSKIP are further discussed below
in Section 3.7.
Fig. 5. RNAi-based knockdown of GSKIP, GSK3α, and GSK3β decreased PKA-mediated Drp1 phosphorylation at Ser637. (A) Q-PCR results showing the relative GSKIP mRNA expression
level with respect to endogenous GSKIP, siRNA-mediated GSKIP knockdown, and GSKIP overexpression in HEK293 cells. Reference value: GFP group. (B) Quantiﬁcation of anti-NF-200-
positive cells in GSKIP knockdown and scrambled control cells. Y-axis is the fraction of cells observed. (C) In the presence of forskolin, siRNA-mediated knockdown of GSKIP expression
and GSKIP overexpression altered phosphorylation of Drp1 Ser637 and GSK3β Ser9, respectively. (D) Knockdown of GSK3β expression altered phosphorylation of Drp1 Ser637.
Knockdown of GSK3α expression (E) or kinase-inactive GSK3β K85R (F) had no effect on Drp1 Ser637 phosphorylation.
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multifaceted signaling
Mitochondrial dynamics is tightly regulated by twomajor subclasses
of proteins, ﬁssion and fusion proteins. Drp1 phosphorylation has been
linked to elongated mitochondrial morphology and resistance to H2O2-
induced cell death. We had expected that all cell types tested in this
study (Fig. 6B) would show a phenotype of mitochondrial fragmenta-
tion, with GSK3β activity affected by H2O2 (Fig. 3, panel H2O2). To the
contrary, when treated with forskolin all cells showed a pattern of elon-
gated mitochondrial morphology (Supplemental Fig. 4). While the
effect of the two GSKIP mutants (V41/L45P and L130P) on apoptosis
was not clear, the co-administration of forskolin and H2O2 resulted in
elongated mitochondria only in cells expressing GSKIP wt (Fig. 6C).
The question of why only GSKIP wt caused the elongatedmitochondrial
morphology in the presence of forskolin and H2O2 warranted further
investigation.
Given the opposing effects of forskolin and H2O2 on mitochondrial
morphology, we further scrutinized the underlying molecular mecha-
nism by which cAMP disrupts the H2O2 insult. We concluded that the
effect may be due to Drp1 phosphorylation, suggesting that Drp1
Ser637 confers mitochondrial elongation. Several of our ﬁndings sup-
port this postulation: 1) The GSKIP V41/L45P mutant is designated to
prevent GSKIP binding to PKA RIIBD; in cells expressing this mutant,
Drp1 S637 was not phosphorylated. 2) The GSKIP L130P mutant is
unable to bind GSK3β, which serves as an anchor protein to recruit
Drp1 for phosphorylation by PKA; cells expressing the L130P mutant
failed tomodulate Drp1 S637 phosphorylation. 3) Under H2O2 treatment,
decreased GSK3β but not PKA activity accounted for the low level of
pS637 Drp1 (Fig. 4, panel H2O2). 4) RNAi-based knockdown of GSKIP
expression resulted in a dramatic decrease in Drp1 S637 phosphorylation
(Fig. 5C). 5) Silencing of GSK3β but not GSK3α resulted in decreased
phosphorylation of Drp1 S637 (Fig. 5D & E), indicating that only GSK3β
is involved in cAMP/PKA/Drp1 axis signaling. Of note, this phenomenonis similar to the functional consequences of the previously reported
GSK3β–K85M mutant, but not the GSK3β–K85R mutant (Fig. 5F) [25].
Together, the data shown in Figs. 4, 5, and 6 (confocal imaging) illustrate
that PKA-mediated Drp1 phosphorylation at S637 and GSK3β-mediated
Drp1 recruitment occur by anchoring, rather than kinase activity, to
modulate mitochondrial morphology.
3.7. A model of GSKIP, GSK3β, PKA RII, and Drp1 interaction
Currently, two interaction patterns are reported for AKAP interaction
with GSK3β, involving MAP2D, AKAP220, GSKIP, PS1 and Cos2. First,
AKAPs facilitate inhibition of GSK3β, including MAP2D, AKAP220, and
GSKIP. Second, the priming of the GSK3β substrate is mediated by
PKA, including PS1 and Cos2 [26,27]. Our convergent results, however,
suggest a third model of AKAP tethering of GSK3β, in which GSK3β
acts as an anchoring protein rather than a kinase. Unlike the interplay
between GSK3β and GSKIP depicted in the ﬁrst model of interaction,
GSKIP tethers GSK3β to anchor Drp1, a mitochondrial ﬁssion protein, to
regulate PKA-mediated phosphorylation of Drp1 at S637. This AKAP-like
action is similar to the reported model of mAKAP/PDE4D3/E-pac1, in
which PDE4D3 functions as an adaptor protein that recruits Epac1 [27].
In light of our ﬁndings, we hypothesize a model for the possible roles of
GSKIP (Fig. 8; Supplemental Fig. 5). Threemechanistic states are proposed
in the model as follows. State 1: while activating cAMP signaling in
the presence of GSKIP, GSKIP wt confers neuroprotection under H2O2-
induced apoptosis. This process includes 3 major events: A) PKA binds
GSKIP wt and facilitates GSK3β S9 phosphorylation. B) GSKIP negatively
regulates GSK3β activity (by protein–protein interaction). The events in
a and b represent a double inhibition of GSK3β activity that leads
to Drp1 phosphorylation at S637 rather than S693. C) GSKIP mediates
Drp1 phosphorylation at S637 by PKA (a novel pathway via GSK3β
anchoring that was identiﬁed in this study; Table 1). State 2: In con-
trast to state 1, in the absence of GSKIP expression to negatively reg-
ulate GSK3β activity, GSK3β may act as a kinase to phosphorylate
Fig. 6.Variations inmitochondrialmorphologywith overexpression ofGFP, GSKIPwt and twoGSKIPmutants under different conditions. (A)HeLa cells transfected for 24hwithGFP vector
or other GFP-tagged GSKIP constructs, including wild-type, L130P, and V41/L45 mutants. (B) The transfected cells were further treated with 500 μM H2O2 for another 24 h. (C) The
transfected cells were pre-conditioned with 10 μM forskolin for 30 min and then treated with 500 μM H2O2 for another 24 h. Mitochondrial morphology of HeLa cells was observed
by staining with Mitotracker under confocal microscopy. Cell nuclei were counter-stained using DAPI. Insets are magniﬁcations of the Mitotracker signals at the indicated areas. Inset 1,
non-transfected cells; inset 2, transfected cells.White arrows indicate elongatedmitochondria forming a net-like pattern.White arrowheads represent the intermediate-typemitochondrial
morphology. Only overexpressed GSKIP wt, not the mutants, caused elongated mitochondrial morphology under co-administration of H2O2 and forskolin. (D) Distributions of the three
major mitochondrial morphologies (fragmented, intermediate and elongated) under different conditions. Estimated based on at least 5 ﬁelds containing 100 transfectant cells/ﬁeld by
confocal imaging. Y axis of the bar chart is the percentage of observed cells containing the speciﬁc mitochondrial morphology.
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Fig. 7. Ectopic expression of Drp1 S637D, but not S637A rescues themitochondrial morphology phenotypes in cells stably expressing either GSKIP L130P or V41/L45P mutants under hy-
drogen peroxide treatment. HeLa cells stably expressing either GSKIP L130P or V41/L45P mutant were transfected with GFP-tagged Drp1S637D and S637A mutants for 24 h. The
transfected cells were pre-treated with 10 μM forskolin for 30 min and treated with 500 μM H2O2 for another 24 h. Mitochondrial morphology of HeLa cells was observed by staining
withMitotracker under confocalmicroscopy. Cell nuclei were counterstained using DAPI. Insets aremagniﬁcations of theMitotracker signal at the indicated areas. Inset 1: non-transfected
cells; inset 2, transfected cells. White arrows indicate elongatedmitochondria forming a net-like pattern.White arrowheads represent the intermediate-type mitochondrial morphology.
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3: Alternatively, GSKIP, as an inhibitor of GSK3β through L130,mediates
β-catenin ubiquitination during differentiation [6].Fig. 8. Schematic of GSKIP, GSK3β, PKA RII, and Drp1 complex regulatingmitochondrial function
peroxide-induced apoptosis via threemodes: a. PKA binds GSKIPwt and facilitates GSK3β Ser9
Refs. [23] and [24]); ⁎⁎inhibition of GSK3β activity. c. GSKIP mediates Drp1 phosphorylation at
mediated phosphorylation of Ser637. This event is thought to exert neuroprotective action
regulatory subunit of PKA. C: catalytic subunit of PKA.Regardless of which prospective regulatory event predominates, our
identiﬁcation of GSKIP as a modulator of mitochondrial biology and
the discovery of an anchored PKA/GSKIP/GSK3/Drp1 axis provide anal.While activating cAMP signaling, GSKIPwt contributes neuroprotection from hydrogen
phosphorylation. b. GSKIP negatively regulates GSK3β activity (previously characterized in
Ser637 by PKA. Basically, GSKIP anchors Drp1 through L130 by tethering GSK3β for PKA-
through mitochondrial elongation: *neuroprotection (see also Supplemental Fig. 5). R:
Table 1
GSKIP functions associated with PKA RII and GSK3 binding sites.
GSKIP
Functions PKA RII GSK3
Neurite outgrowth − +
Anchoring + +
Drp1 phosphorylation +* +†
+, involved;−, not involved; *S637; † at S637, GSK3β as anchoring (this study); at S40,
S44 (Ref. [18]); at S693 (Ref. [7]).
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regulating Drp1 phosphorylation during the dynamic mitochondrial
response to H2O2-induced apoptosis [7,26]. It is worth noting that
recent studies have shown that the PKA/AKAP1/Drp1 complex also
plays a role in mitochondrial function [17,28]. Further studies should be
conducted to determine whether these two AKAPs, GSKIP and AKAP1,
have competitive, cooperative or distinctive functions and to determine
their corresponding locations in Drp1-dependent mitochondrial ﬁssion.3.8. Animal models of the PKA/GSKIP/GSK3/Drp1 signaling axis
Previous studies reported that Drp1 mutant or knockout (KO) led to
early embryonic death and defective neurodevelopment [29–33]. In
addition, GSK3β KO brought about developmental defects [34] due to
hepatic apoptosis or cardiac patterning [35]. Studies also showed that
PKA KO caused embryonic lethal and spinal neural tube defects [36].
These data collectively led us to believe that GSKIP may have a role in
neurodevelopment. Our newmodel (Fig. 8; Supplemental Fig. 5) clearly
demonstrates that GSKIP is one of the major regulators of Drp1 S637
phosphorylation. It should be noted that some discrepancy may exist
between results observed in cultured cells and in embryonic develop-
ment, since we were unable to observe the functional consequences of
neurite outgrowth after knockdown of GSKIP (Fig. 5B). The fact that
homologous GSKIP KO mice exhibited developmental lethality (data
not shown) suggests that GSKIP is also important during development.
The discrepancies between GSKIP knockdown in cultured cells and GSKIP
KO mice could indicate that a partial deﬁciency in GSKIP expression may
not have an evident phenotypic effect in neuronal development, or that
other GSK3 signaling downstream events might counteract the action of
GSKIP. To substantiate our proposed model, we plan to breed mice with
tissue-speciﬁc GSKIP KO in the central nervous system to elucidate the
role of GSKIP in neurodevelopment. A better understanding at themolec-
ular level of the PKA/GSKIP/GSK3/Drp1 axis and the PKA signaling path-
ways involved in the pathogenesis of neurodegenerative diseases would
help advance drug development for neuron-related disorders such as
Alzheimer's disease [18].4. Conclusions
In this study, we provided evidence that GSKIP and GSK3β play
central roles in the cAMP/PKA/GSKIP/GSK/Drp1 axis signaling that causes
mitochondrial elongation under oxidative stress. Notably, GSKIP helps
drive PKA-mediated Drp1 phosphorylation at Ser637 rather than Ser693
by tethering GSK3β. The GSKIP anchoring function of GSK3β is reported
in this study for the ﬁrst time. Particularly, we found that GSK3β partici-
pates in this axis as an anchoring protein, not a kinase. Ourmajor ﬁndings
may provide new insights into themultifaceted roles of GSK3β in cellular
signaling and indicate the possible pharmaceutical use of GSKIP.Transparency document
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